Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes

Kaisa M Kemppainen1, Alexandria N Ardissone1, Austin G Davis-Richardson1

  • 1Department of Microbiology and Cell Science, Institute of Food and Agricultural Sciences, University of Florida, Gainesville, FL.

Diabetes Care
|December 19, 2014
PubMed

Insights

Geographical location significantly impacts the gut microbiome in infants at high risk for type 1 diabetes. These early-life gut bacteria patterns vary by country, influencing future disease research.

Area of Science:

  • Microbiome research
  • Pediatric health
  • Type 1 diabetes research

Background:

  • Gut microbiome dysbiosis is linked to various diseases, including type 1 diabetes.
  • Infant gut microbiome development is crucial for immune system maturation.
  • Understanding environmental influences on the infant microbiome is key for disease prevention.

Purpose of the Study:

  • To investigate the effect of geographical location on the gut microbiome of high-risk infants.
  • To analyze microbiome differences in infants across diverse geographical sites.
  • To assess the influence of location on early-life gut colonization patterns.

Main Methods:

  • Pilot study involving 90 high-risk, nonautoimmune infants.
  • Stool sample collection within The Environmental Determinants of Diabetes in the Young (TEDDY) study.
  • High-throughput 16S rRNA sequencing for microbiome analysis.

Main Results:

  • Geographical location showed distinct patterns in gut microbial colonization across continents.
  • Finland and Colorado exhibited significantly lower bacterial diversity.
  • Sweden and Washington state showed early-life dominance of Bifidobacterium.

Conclusions:

  • Infant gut microbiome composition is significantly associated with geographical origin.
  • Geographical factors must be considered in future studies of microbiome-related disease phenotypes.
  • Location-specific microbiome profiles may influence type 1 diabetes risk.
Abstract

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
6
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
53
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
92.7K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
48
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
6
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
2